WATERTOWN, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (NASDAQ: ACUS) today announced that the journal Future Drugs recently published an overview on Imagify™ (perflubutane polymer microspheres) injectable suspension. This publication is authored by Dr. Roxy Senior, Consultant Cardiologist and Director of Cardiac Research, Department of Cardiovascular Medicine and Institute of Postgraduate Medical Education and Research at Northwick Park Hospital in the U.K. Dr. Senior is also a Hon Professor, Middlesex University, London, U.K. and Imagify clinical investigator. In the publication, Dr. Senior describes Imagify, its clinical development and his views on how the investigational drug is positioned to influence the evolving discipline of myocardial contrast echocardiography for the assessment of myocardial perfusion (blood flow in the heart muscle). The article looks at Imagify clinical trial results through its Phase 3 pilot study.
